Tenofovir Alafenamide (Taf) Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 25 mg TAF per tablet

Reference Brands: Vemlidy® (EU & US)

Category: Hepatitis

Tenofovir Alafenamide (TAF) is available in Tablet and strengths such as 25 mg TAF per tablet. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tenofovir Alafenamide (TAF) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Tenofovir Alafenamide (TAF) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Tenofovir Alafenamide (TAF) is a next-generation nucleotide reverse transcriptase inhibitor (NRTI) used for the treatment of chronic Hepatitis B virus (HBV) infection and HIV-1. Available as oral tablets, typically in 25 mg strength, TAF delivers higher intracellular concentrations of the active drug with lower plasma exposure, improving safety and reducing kidney and bone side effects compared to Tenofovir Disoproxil Fumarate (TDF). Marketed under the brand name Vemlidy® (for HBV) and as part of combination therapies for HIV, TAF is FDA- and EMA-approved, widely used by pharma B2B suppliers and healthcare providers in the US and EU.